A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04 |
I |
Monday, November 11, 2013 |
United States of America |
Women |
1% tenofovir gel, HEC gel, tenofovir |
Completed |
January 2015 |
A13-128 |
I |
Sunday, November 30, 2014 |
United States of America, Dominican Republic |
Women |
TFV ring, TFV/LNG ring |
Completed |
November 2015 |
CAPRISA 004 |
IIb |
Tuesday, May 1, 2007 |
South Africa |
Women |
1% tenofovir gel |
Completed |
March 2010 |
CAPRISA 008 |
III, II |
Wednesday, October 31, 2012 |
South Africa |
Women |
1% tenofovir gel |
Completed |
December 2015 |
Comparison of Tenofovir Vaginal Gel and Film Formulations (FAME-05) |
Open Label |
Tuesday, November 11, 2014 |
|
Women |
1% tenofovir gel, tenofovir |
Completed |
December 1015 |
CONRAD 117 |
I |
Thursday, February 28, 2013 |
United States of America |
Women |
1% tenofovir gel, FTC, TVF/FTC |
Completed |
January 2014 |
CONRAD 118 |
I |
Tuesday, December 31, 2013 |
United States of America |
Women |
1% tenofovir gel, Contraceptive Vaginal Ring, Metronidazole, Terconazole |
Completed |
December 2014 |
CONRAD 120 |
I |
Saturday, June 30, 2012 |
United States of America |
Women |
1% tenofovir gel |
Completed |
December 2012 |
CONRAD 128 |
I |
Saturday, October 11, 2014 |
Dominican Republic, United States of America |
Women |
tenofovir, Levonorgestrel |
Completed |
December 2015 |
CONRAD A10-114 |
I |
Saturday, March 31, 2012 |
United States of America, Dominican Republic |
Women |
1% tenofovir gel, DMPA |
Completed |
March 2014 |